Improving nanotherapeutic vaccine delivery
Northwestern Medicine scientists have developed a more effective way of creating nanotherapeutic vaccines and medicines, according to a new study published in ACS Nano.
See also stories tagged with Oncology
Northwestern Medicine scientists have developed a more effective way of creating nanotherapeutic vaccines and medicines, according to a new study published in ACS Nano.
Golden retrievers are one of the most popular breeds of dogs. But research shows they have up to a 65% chance of dying from cancer. In a new study, University of California, Davis, researchers set out to find if certain genetic ...
Experts from ETH Zurich, the University of Zurich, and the University Hospital Zurich have used machine learning to jointly create an innovative method to predict how individual cells react to specific treatments, offering ...
According to textbooks, proteins work by folding into stable 3D shapes that, like Lego blocks, precisely fit with other biomolecules.
In a paper published in the Journal of Chemical Technology and Biotechnology, a multidisciplinary team including biologists, chemists, chemical engineers, and environmental scientists have investigated the characteristics ...
As befits the child of a scientist, Martin Picard's young son, 3, is already learning about biology with an age-appropriate textbook, "Cell Biology for Babies." Picard winces a little whenever the book calls mitochondria ...
Researchers at The University of Texas MD Anderson Cancer Center have discovered that certain nano-based cancer therapies may be less effective in younger patients, highlighting the need for further investigation into the ...
Researchers at Uppsala University, Stockholm University and KTH Royal Institute of Technology have managed to create a new spatial omics method. By combining two complex techniques that are usually used separately—mass spectrometry ...
Using a novel proteogenomic strategy and a variety of machine learning tools, investigators from the Icahn School of Medicine at Mount Sinai and colleagues have identified a 64-protein signature that may predict a subset ...
Researchers at Tel Aviv University have destroyed 90% of multiple myeloma blood cancer cells under laboratory conditions, and 60% in human tissues taken from patients at Rabin Medical Center (Belinson Hospital), using an ...